Man Group plc - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,503,468
+20.4%
605,743
-1.7%
0.05%
+21.4%
Q2 2023$13,704,332
-4.1%
615,925
-6.7%
0.04%
-17.6%
Q1 2023$14,295,492
+2.7%
659,995
-3.7%
0.05%
+2.0%
Q4 2022$13,920,190
-27.5%
685,386
-8.4%
0.05%
-43.8%
Q3 2022$19,189,000
-27.0%
748,401
-32.3%
0.09%
-19.8%
Q2 2022$26,287,000
+161.9%
1,105,432
+148.0%
0.11%
+217.1%
Q1 2022$10,038,000
+12.6%
445,740
-1.0%
0.04%
+20.7%
Q4 2021$8,918,000
+11.1%
450,414
+10.4%
0.03%
+3.6%
Q3 2021$8,027,000
-2.2%
407,865
+9.3%
0.03%
-3.4%
Q2 2021$8,207,000
+19.5%
373,047
+29.2%
0.03%
-3.3%
Q1 2021$6,870,000
-19.5%
288,755
-11.5%
0.03%
-18.9%
Q4 2020$8,537,000
-36.8%
326,330
-58.0%
0.04%
-30.2%
Q3 2020$13,509,000
+63.6%
776,128
+58.1%
0.05%
+26.2%
Q2 2020$8,258,000
-7.6%
490,954
-34.7%
0.04%
-27.6%
Q1 2020$8,938,000
+24.0%
751,707
+26.2%
0.06%
+141.7%
Q4 2019$7,209,000
+131.1%
595,795
+169.9%
0.02%
+100.0%
Q3 2019$3,120,000
+58.5%
220,762
+25.1%
0.01%
+71.4%
Q2 2019$1,968,000
-61.7%
176,454
-59.7%
0.01%
-65.0%
Q1 2019$5,140,000
+31.9%
437,817
+50.1%
0.02%
+17.6%
Q4 2018$3,898,000
-40.9%
291,769
-38.0%
0.02%
-29.2%
Q3 2018$6,595,000
+210.8%
470,392
+248.5%
0.02%
+166.7%
Q2 2018$2,122,000
-32.0%
134,983
-28.8%
0.01%
-35.7%
Q1 2018$3,120,000189,6330.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders